DE69736180D1 - Behandlung von manischen erkrankungen - Google Patents

Behandlung von manischen erkrankungen

Info

Publication number
DE69736180D1
DE69736180D1 DE69736180T DE69736180T DE69736180D1 DE 69736180 D1 DE69736180 D1 DE 69736180D1 DE 69736180 T DE69736180 T DE 69736180T DE 69736180 T DE69736180 T DE 69736180T DE 69736180 D1 DE69736180 D1 DE 69736180D1
Authority
DE
Germany
Prior art keywords
treatment
manical
diseases
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69736180T
Other languages
English (en)
Other versions
DE69736180T2 (de
Inventor
Anders Fink-Jensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of DE69736180D1 publication Critical patent/DE69736180D1/de
Application granted granted Critical
Publication of DE69736180T2 publication Critical patent/DE69736180T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
DE69736180T 1996-07-31 1997-07-25 Behandlung von manischen erkrankungen Expired - Lifetime DE69736180T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK82496 1996-07-31
DK82496 1996-07-31
PCT/DK1997/000320 WO1998005330A1 (en) 1996-07-31 1997-07-25 Treatment of psychotic disorders

Publications (2)

Publication Number Publication Date
DE69736180D1 true DE69736180D1 (de) 2006-08-03
DE69736180T2 DE69736180T2 (de) 2007-06-14

Family

ID=8097971

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69736180T Expired - Lifetime DE69736180T2 (de) 1996-07-31 1997-07-25 Behandlung von manischen erkrankungen

Country Status (18)

Country Link
US (1) US5914333A (de)
EP (1) EP0920316B1 (de)
JP (1) JP2000515156A (de)
KR (1) KR20000029525A (de)
CN (1) CN1226828A (de)
AT (1) ATE330604T1 (de)
AU (1) AU728191B2 (de)
BR (1) BR9710893A (de)
CA (1) CA2260863C (de)
CZ (1) CZ29899A3 (de)
DE (1) DE69736180T2 (de)
ES (1) ES2268732T3 (de)
HU (1) HUP9904030A3 (de)
IL (1) IL128028A0 (de)
NO (1) NO990450L (de)
PL (1) PL331321A1 (de)
WO (1) WO1998005330A1 (de)
ZA (1) ZA976854B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
DE69803670T2 (de) * 1997-08-01 2002-11-21 Elan Corp Plc Dublin Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
EA011094B1 (ru) * 1999-07-01 2008-12-30 Фармация Энд Апджон Компани Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
US6270438B1 (en) * 1999-12-22 2001-08-07 Yuan-Cheng Liao Combination driving hub for bicycle
US20050070524A1 (en) * 2003-06-06 2005-03-31 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders
US20090139311A1 (en) 2007-10-05 2009-06-04 Applied Biosystems Inc. Biological Analysis Systems, Devices, and Methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383999A (en) * 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5750140A (en) * 1994-05-20 1998-05-12 Novo Nordisk A/S Transdermal delivery of tiagabine
US5767117A (en) * 1994-11-18 1998-06-16 The General Hospital Corporation Method for treating vascular headaches
BR9608120A (pt) * 1995-05-05 1999-02-09 Novo Nordisk As Composição farmacêutica e processo para a preparação da mesma
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
UA52661C2 (uk) * 1996-06-14 2003-01-15 Ново Нордіск А/С Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
DK174041B1 (da) * 1998-11-26 2002-05-06 Monarflex As Gennemføring til montering i en fleksibel membran

Also Published As

Publication number Publication date
NO990450D0 (no) 1999-01-29
NO990450L (no) 1999-01-29
CN1226828A (zh) 1999-08-25
IL128028A0 (en) 1999-11-30
PL331321A1 (en) 1999-07-05
WO1998005330A1 (en) 1998-02-12
CA2260863C (en) 2008-02-12
ZA976854B (en) 1998-03-19
EP0920316B1 (de) 2006-06-21
AU3619797A (en) 1998-02-25
AU728191B2 (en) 2001-01-04
BR9710893A (pt) 1999-08-17
ES2268732T3 (es) 2007-03-16
EP0920316A1 (de) 1999-06-09
JP2000515156A (ja) 2000-11-14
CZ29899A3 (cs) 1999-06-16
HUP9904030A2 (hu) 2000-05-28
US5914333A (en) 1999-06-22
HUP9904030A3 (en) 2000-07-28
ATE330604T1 (de) 2006-07-15
KR20000029525A (ko) 2000-05-25
CA2260863A1 (en) 1998-02-12
DE69736180T2 (de) 2007-06-14

Similar Documents

Publication Publication Date Title
ATE200863T1 (de) Indolinonverbindungen zur behandlung von krankheiten
DK0841928T3 (da) Sustained release-formulering af d-threo-methylphenidat
DE69536017D1 (de) Methoden und zusammensetzungen für die behandlung von glomerulonephritis
DE69927823T2 (de) Hydrogel für die therapeutische behandlung von aneurysmas
DE59608738D1 (de) Verwendung von epinastin für die behandlung von schmerzen
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
DE69718731D1 (de) Kombinationstherapie für die Behandlung von Psychosen
DE69822665D1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
NO961483L (no) Fremgangsmåte for behandling av oljeholdig formasjon
DE69534908D1 (de) Verwendung von statin zur behandlung von hauterkrankungen
DE60139466D1 (de) Behandlung von diabetes
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
DE69613386T2 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
DE69736180D1 (de) Behandlung von manischen erkrankungen
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
BR0012921A (pt) Compostos calcilìticos
DE69622889T2 (de) Substituierte 4-(1h-benzimidazol-2-yl)(1,4)diazepane für die behandlung von allergischen krankheiten
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
DE60005685D1 (de) Oxazinocarbazole zur behandlung von cns-erkrankungen
DE69917445D1 (de) Reinigung von carboxaldehyd
DE69601154D1 (de) Zubereitungen für die Behandlung von Hepatitis C
DE19581565T1 (de) Behandlung von unerwünschten organischen Halogenverbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition